Apeiron RIA’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$257K Sell
1,011
-810
-44% -$189K 0.07% 145
2026
Q1
$445K Sell
1,821
-106
-6% -$24.7K 0.1% 124
2025
Q4
$443K Sell
1,927
-380
-16% -$75.1K 0.09% 129
2025
Q3
$440K Buy
2,307
+38
+2% +$6.51K 0.1% 132
2025
Q2
$347K Sell
2,269
-218
-9% -$33.5K 0.09% 156
2025
Q1
$413K Sell
2,487
-109
-4% -$17.1K 0.12% 135
2024
Q4
$375K Buy
2,596
+396
+18% +$61.4K 0.11% 143
2024
Q3
$357K Buy
2,200
+42
+2% +$6.69K 0.1% 146
2024
Q2
$315K Buy
2,158
+294
+16% +$43.7K 0.1% 157
2024
Q1
$295K Sell
1,864
-1,978
-51% -$315K 0.09% 170
2023
Q4
$602K Buy
3,842
+42
+1% +$6.44K 0.19% 90
2023
Q3
$592K Buy
3,800
+145
+4% +$23.9K 0.2% 88
2023
Q2
$605K Buy
3,655
+31
+0.9% +$5K 0.21% 82
2023
Q1
$584K Sell
3,624
-108
-3% -$17.4K 0.2% 85
2022
Q4
$659K Buy
3,732
+76
+2% +$13.1K 0.25% 76
2022
Q3
$596K Buy
3,656
+102
+3% +$17.3K 0.27% 70
2022
Q2
$3.72K Sell
3,554
-194
-5% -$34.6K 1.04% 10
2022
Q1
$682K Sell
3,748
-506
-12% -$86.1K 0.33% 61
2021
Q4
$728K Buy
+4,254
New +$696K 0.3% 68

Other funds holding JNJ

Apeiron RIA's JNJ Position: Q2 2026 in Review

Apeiron RIA reduced its Johnson & Johnson (JNJ) stake by 44% in Q2 2026, selling an estimated $189K and leaving 1,011 shares worth $257K. The position accounts for 0.07% of the portfolio, ranked #145.

Apeiron RIA first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. The position peaked at $728K in Q4 2021. 1,173 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Apeiron RIA held 1,011 shares of Johnson & Johnson worth $257K as of Q2 2026.
  • Apeiron RIA sold 810 Johnson & Johnson shares in Q2 2026, an estimated $189K.
  • Johnson & Johnson made up 0.07% of Apeiron RIA's portfolio in Q2 2026, its #145 holding.
  • Apeiron RIA first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
  • Apeiron RIA's Johnson & Johnson position peaked at $728K in Q4 2021.
  • 1,173 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Apeiron RIA's 13F filing for Q2 2026, filed 16 Jul 2026.